FDA appeals “morning after” pill ruling

Agency seeks to overturn ruling requiring it to make pill available over-the-counter to women of all ages

The Food and Drug Administration (FDA) is fighting back against a recent decision that struck down restrictions on the “morning after” pill.

Last month, a district judge ordered the FDA to make the emergency contraception pill available to women of all ages and without a prescription within 30 days. Currently, the government enforces age restrictions on nonprescription sales of the morning-after pill to girls who are 16 years old or younger. Reproductive rights advocates have long petitioned the FDA to strike down the restrictions, saying there is no scientific proof that girls younger than 17 couldn’t safely use the drug without supervision.

Facing the 30-day deadline, the FDA yesterday filed an appeal with the 2nd Circuit. The Department of Justice also asked the district court for a temporary injunction on the order while the appeal is pending.

Read more at Thomson Reuters.

For more InsideCounsel stories about legal battles over contraception, read:

Judge strikes down restrictions on “morning after” pill

Federal Circuit invalidates Bayer’s Yaz patent

Bayer settles claims of gallbladder injury caused by Yasmin and Yaz contraceptives

Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives

Court denies contraception coverage injunction

Birth control exemptions fail to stop lawsuits

Hobby Lobby loses appeal of contraception coverage

Hobby Lobby must cover morning-after pill, judge rules

Obamacare faces another lawsuit over contraception coverage

Woman sues birth control pill maker for unintended pregnancy

Join the Conversation

Advertisement. Closing in 15 seconds.